US Pharma MarketingAmwell boasts higher than expected renewals, retention despite Q1 revenue decline
Amwell boasts higher than expected renewals, retention despite Q1 revenue decline is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The telehealth platform brought in $54.9 million in Q1 2026 revenue.
Source: Fierce Healthcare